AstraZeneca Pharma India Ltd has announced that the Board of Directors of the Company at its meeting held on March 17, 2007, inter alia, has transacted / approved the following:
1. The Board has revoked the dividend of Rs 12/- per equity share (face value of Rs 2/- each), recommended earlier at its meeting held on February 23, 2007.
2. The Board has declared an Interim Dividend of Rs 12/- per equity share (face value of Rs 2/- each), for the year ended December 31, 2006.
3. Revised Audited Accounts for the year ended December 31, 2006, after necessary changes as to revocation of recommended dividend and payment of Interim Dividend as above, was approved by the Board.